The Chemistry of Neutron Capture Therapy. (Chem. Rev. 1998, 98, 1515. Published on the Web May 20, 1998)
Soloway, A.H..; Tjarks, W.; Barnum, B.A..; Rong, F-Guang.; Barth, R.F..; Codogni, I.M..; Wilson, J..Gerald.
Chemical Reviews 98(6): 2389-2390
1998
ISSN/ISBN: 0009-2665 PMID: 11848966 Document Number: 494328
Document emailed within 1 workday
Related Documents
Wambersie, A.; Menzel, H.G. 1993: RBE in fast neutron therapy and in boron neutron capture therapy. a useful concept or a misuse? Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 169(1): 57-64Matalka, K.Z.; Bailey, M.Q.; Barth, R.F.; Staubus, A.E.; Soloway, A.H.; Moeschberger, M.L.; Coderre, J.A.; Rofstad, E.K. 1993: Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent Cancer Research 53(14): 3308-3313
Gahbauer, R.; Kanellitsas, C.; Blue, T.; Wang, C.; Clendenon, N.; Fairchild, R.; Laster, B.; McGregor, J.; Goodman, J. 1989: Dose bracketing in boron neutron capture therapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 229-230
Hatanaka, H.; Amano, K.; Sano, K.; Mogami, H.; Hayakawa, T. 1974: Boron-10-slow neutron capture therapy for brain tumors No Shinkei Geka. Neurological Surgery 2(1): 7-16
Allen, B.J. 1990: The potential of neutron capture therapy in the management of uncontrollable localised tumours Australasian Radiology 34(4): 297-305
Hatanaka, H.; Sano, K.; Yasukochi, H. 1988: Boron-neutron capture therapy in brain tumors and other cancers--a radiosurgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Pt: 2-2): 1115-1123
Matsumura, A.; Zhang, T.; Nakai, K.; Endo, K.; Kumada, H.; Yamamoto, T.; Yoshida, F.; Sakurai, Y.; Yamamoto, K.; Nose, T. 2005: Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study Journal of Experimental and Clinical Cancer Research: Cr 24(1): 93-98
Beauduin, M.; Gueulette, J.; Grégoire, V.; De Coster, B.M.; Vynckier, S.; Wambersie, A. 1990: Radiobiological comparison of fast neutron beams used in therapy. Survey of the published data Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 166(1): 18-21
Mill, A.J. 1989: Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 193-196
Dorn, R.V.; Spickard, J.H.; Griebenow, M.L. 1989: A proposed protocol for clinical trials of boron neutron capture therapy in glioblastoma multiforme Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 233-234
Tamat, S.R.; Patwardhan, A.; Moore, D.E.; Kabral, A.; Bradstock, K.; Hersey, P.; Allen, B.J. 1989: Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 145-147
Yong, J.H.; Barth, R.F.; Wyzlic, I.M.; Soloway, A.H.; Rotaru, J.H. 1995: In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy Anticancer Research 15(5b): 2033-2038
Al-Samarrai, S.F.; Takeuchi, A.; Hatanaka, H. 1975: Electron microscopic study on the response of the normal canine brain to boron-neutron capture therapy Gan 66(6): 663-672
Laster, B.H.; Kahl, S.B.; Popenoe, E.A.; Pate, D.W.; Fairchild, R.G. 1991: Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture Cancer Research 51(17): 4588-4593
Wambersie, A.; Scalliet, P. 1989: Clinical implementation in BNCT (boron neutron capture therapy): fractionated versus protracted low dose rate irradiation Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(5): 407-411
Montagno, E.d.A.; Moreira Filho, L.; Hatanaka, H. 1989: Three cases of terminal stage malignant gliomas in which the diffusely disseminated intraventricular tumors became the target of boron neutron capture therapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 238-240
Takagaki, M.; Ono, K.; Oda, Y.; Kikuchi, H.; Nemoto, H.; Iwamoto, S.; Cai, J.; Yamamoto, Y. 1996: Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors Cancer Research 56(9): 2017-2020
Weinstock, I..A.. 1998: Homogeneous-Phase Electron-Transfer Reactions of Polyoxometalates.[(Chem. Rev. 1998, 98, 113 (this issue). Published on the Web January 22, 1998. Chemical Reviews 98(1): 389-390
Schwarz, R.; Brockmann, W.P.; Junker, A. 1989: Results of fast neutron therapy of adenoid-cystic carcinomas of the head and neck at the neutron therapy facility Hamburg-Eppendorf Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(4): 313-314
Yong, J.H.; Barth, R.F.; Rotaru, J.H.; Wyzlic, I.M.; Soloway, A.H. 1995: Evaluation of in vitro cytotoxicity of carboranyl amino acids, their chemical precursors and nido carboranyl amino acids for boron neutron capture therapy Anticancer Research 15(5b): 2039-2043